Alera Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Alera Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$327K	Buy	6,329 +867	+16%	+$40.7K	0.04%	194
2024 Q2	$227K	Sell	5,462 -9,934	-65%	-$445K	0.03%	239
2024 Q1	$835K	Buy	15,396 +3,584	+30%	+$183K	0.11%	80
2023 Q4	$606K	Sell	11,812 -1,000	-8%	-$52.5K	0.08%	105
2023 Q3	$744K	Buy	12,812 +61	+0.5%	+$3.74K	0.12%	74
2023 Q2	$815K	Buy	12,751 +3,396	+36%	+$228K	0.18%	69
2023 Q1	$648K	Sell	9,355 -63	-0.7%	-$4.44K	0.15%	85
2022 Q4	$678K	Sell	9,418 -2,501	-21%	-$189K	0.16%	79
2022 Q3	$848K	Sell	11,919 -2,474	-17%	-$179K	0.24%	50
2022 Q2	$1.11M	Sell	14,393 -276	-2%	-$21K	0.31%	40
2022 Q1	$1.07M	Buy	+14,669	New	+$985K	0.25%	49
2019 Q2	–	Sell	-1,680	Closed	-$80K	–	197
2019 Q1	$80K	Sell	1,680 -431	-20%	-$21.5K	0.04%	120
2018 Q4	$110K	Buy	+2,111	New	+$113K	0.07%	107

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alera Investment Advisors's BMY Position: Q3 2024 in Review

Alera Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 16% in Q3 2024, buying an estimated $40.7K and bringing the position to 6,329 shares worth $327K. The position accounts for 0.04% of the portfolio, ranked #194.

Alera Investment Advisors first reported a position in BMY in Q4 2018 and has held it in 13 quarters since. The position peaked at $1.11M in Q2 2022. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

Alera Investment Advisors held 6,329 shares of Bristol-Myers Squibb worth $327K as of Q3 2024.
Alera Investment Advisors bought 867 Bristol-Myers Squibb shares in Q3 2024, an estimated $40.7K.
Bristol-Myers Squibb made up 0.04% of Alera Investment Advisors's portfolio in Q3 2024, its #194 holding.
Alera Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 13 quarters since.
Alera Investment Advisors's Bristol-Myers Squibb position peaked at $1.11M in Q2 2022.
2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Alera Investment Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.